FDA Reaches Out to Recently Fired Scientists Amid Neuralink Review

The FDA is considering rehiring recently dismissed scientists who were involved in projects like Elon Musk's Neuralink. About 300 positions are expected to be reinstated after mass firings by the Trump administration. The decision follows criticism of the agency's staffing cuts, affecting various critical sectors.

The U.S. Food and Drug Administration is reaching out to recently dismissed scientists, including those who reviewed Elon Musk's Neuralink, seeking their return. This comes on the heels of extensive firings authorized by the Trump administration, affecting around 1,000 FDA staffers.

Sourced information suggests the FDA intends to reinstate approximately 300 jobs, with claims that the cuts were driven by a governmental efficiency initiative led by Musk himself. At least 11 scientists at the FDA's Center for Devices and Radiological Health have already been contacted to rejoin.

Critics argue the firings contradict stated goals of fiscal saving, as many affected roles were financed by industry fees rather than taxes. AdvaMed CEO Scott Whitaker emphasized the need for a robust FDA to ensure the safety of medical devices. Meanwhile, questions about the motive and aftermath of the firings persist.

(With inputs from agencies.)